Calif. Court Revives Avandia Injury Claims Against GSK
A California appeals court on Monday revived claims brought by non-English speakers who allege GlaxoSmithKline failed to warn them about the cardiovascular risks of its Type 2 diabetes drug Avandia, finding...To view the full article, register now.
Already a subscriber? Click here to view full article